Ingrid E. Wertz - Concepedia

Author

Ingrid E. Wertz

Also Known As

I E Wertz, I WERTZ, I Wertz, I. E. Wertz, Ingrid E Wertz, Ingrid E. Wertz, Ingrid Wertz, Ingrid E. Wertz, Wertz, Ingrid E.

Publications

11.4K

Citations

H-Index

Concepts

All Affiliations

University of California, Davis Molecular Oncology (United States)University of California, San Francisco Gene Therapy Laboratory Bristol-Myers Squibb (United States)

About

Ingrid E. Wertz is an author at University of California, Davis specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	27	7.5K
2	Natural Sciences	7	7	786
3	Biochemistry	5	5	458
4	Engineering	1	1	54
5	Allergy	1	1	69

Ingrid E. Wertz

Publications

Citations

H-Index

Page 1

	Year	Citations
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling Ingrid E. Wertz, Karen O’Rourke, Honglin Zhou, Nature Signal TransductionCell RegulationMolecular PathwayMolecular RegulationSignaling Pathway	2004	1.8K
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7 Ingrid E. Wertz, Saritha Kusam, Cynthia Lam, Nature Protein FunctionMedicineImmune Checkpoint InhibitorCancer BiologyCytoskeleton	2011	806
The ubiquitin ligase COP1 is a critical negative regulator of p53 David Dornan, Ingrid E. Wertz, Harumi Shimizu, Nature Cell RegulationMolecular RegulationCritical Negative RegulatorMolecular BiologyCell Death	2004	701
Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease Qing Zhou, Hongying Wang, Daniella M. Schwartz, Nature Genetics InflammationRheumatologyA20 Haploinsufficiency CauseAutoimmune DiseaseAutoantibody Production	2015	601
Ubiquitin Chain Editing Revealed by Polyubiquitin Linkage-Specific Antibodies Kim Newton, M Matsumoto, Ingrid E. Wertz, Cell Ubiquitin Chain EditingAutoimmune DiseaseImmunologyAutoimmunityAntibody Engineering	2008	550
Bcl10 activates the NF-κB pathway through ubiquitination of NEMO Honglin Zhou, Ingrid E. Wertz, Karen O’Rourke, Nature Signal TransductionSignaling PathwayCell RegulationImmunologyNf-κb Pathway	2003	524
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax) H Zhang, J Chen, Sajid Khan Tahir, Cell Death and Disease	2015	427
Human De-Etiolated-1 Regulates c-Jun by Assembling a CUL4A Ubiquitin Ligase Ingrid E. Wertz, Karen O’Rourke, Zemin Zhang, Science	2004	366
USP7 small-molecule inhibitors interfere with ubiquitin binding Lorna Kategaya, Paola Di Lello, Lionel Rougé, Nature Molecular DockingUbiquitin BindingDrug TargetMedicineNatural Sciences	2017	332
Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation Ingrid E. Wertz, Kim Newton, Dhaya Seshasayee, Nature InflammationAnti-inflammatoryAutoimmune DiseaseMedicineImmunology	2015	251

Page 1